Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: David Suhy

Benitec – gene silencing by ddRNAi

Posted on by

DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.

Benitec – gene silencing by ddRNAi

Benitec

Continue reading →

Posted in Biotech Companies, Biotech Companies Australia, Biotech Companies USA | Tagged AAV, adenovirus, AIDS, Benitec, Benitec - gene silencing by ddRNAi, Benitec Biopharma, BenitecBiopharma, Carl Stubbings, David Suhy, ddRNAi, DNA, DNA-directed RNA Interference, double stranded RNA, dsRNA, gene silencing, gene silencing by ddRNAi, gene silencing ddRNAi, Greg West, Hepatitis B, Hepatitis C, HIV, human cancer vaccines, Huntington's Disease, Iain Ross, John Chiplin, Kevin Buchi, lentivirus, lung cancer, Michael Graham, modified polyethylenimine, muscular dystrophy, oculopharyngeal, orphan genetic disease, Peter Francis, Peter French, Retinitis Pigmentosa, RNA, RNAi, short hairpin RNA, shRNA, siRNA, wet Age-related Macular Degeneration

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress